公开(公告)号：US20180186818A1

公开(公告)日：2018-07-05

申请号：US15736677

申请日：2016-06-14

申请人： UBE INDUSTRIES, LTD.

发明人： Noriaki IWASE ,  Yasuhiro AGA ,  Shigeru USHIYAMA ,  Shigeyuki KONO ,  Hidetoshi SUNAMOTO ,  Takashi MATSUSHITA ,  Sayaka OGI ,  Satoshi UMEZAKI ,  Masahiro KOJIMA ,  Kazuhiro ONUMA ,  Yusuke SHIRAISHI ,  Makoto OKUDO ,  Tomio KIMURA

IPC分类号： C07F7/08 ,  A61P35/00 ,  A61K31/695 ,  A61K45/06

CPC分类号： C07F7/0812 ,  A61K31/695 ,  A61K45/06 ,  A61P35/00 ,  C07F7/10 ,  C07F7/12

摘要： The present invention provides a compound represented by the general formula (Ia) or a pharmacologically acceptable salt thereof. In the general formula (Ia), two R moieties each independently represent a C1-3 alkyl group or the like; and R1, R2 and R3 each independently represent an optionally substituted linear or branched C1-4 alkyl group.

公开(公告)号：US20190256531A1

公开(公告)日：2019-08-22

申请号：US16373840

申请日：2019-04-03

申请人： UBE INDUSTRIES, LTD.

发明人： Noriaki IWASE ,  Yasuhiro AGA ,  Shigeru USHIYAMA ,  Shigeyuki KONO ,  Hidetoshi SUNAMOTO ,  Takashi MATSUSHITA ,  Sayaka OGI ,  Satoshi UMEZAKI ,  Masahiro KOJIMA ,  Kazuhiro ONUMA ,  Yusuke SHIRAISHI ,  Makoto OKUDO ,  Tomio KIMURA

IPC分类号： C07F7/08 ,  A61K45/06 ,  A61P35/00 ,  A61K31/695 ,  C07F7/10 ,  C07F7/12

摘要： The present invention provides a compound represented by the general formula (Ia) or a pharmacologically acceptable salt thereof. In the general formula (Ia), two R moieties each independently represent a C1-3 alkyl group or the like; and R1, R2 and R3 each independently represent an optionally substituted linear or branched C1-4 alkyl group.

公开(公告)号：US20170313727A1

公开(公告)日：2017-11-02

申请号：US15522592

申请日：2015-10-30

申请人： UBE INDUSTRIES, LTD.

发明人： Yasuhiro AGA ,  Shigeru USHIYAMA ,  Noriaki IWASE ,  Shigeyuki KONO ,  Hidetoshi SUNAMOTO ,  Takashi MATSUSHITA ,  Sayaka OGI ,  Masayuki TANAKA ,  Masaaki MATOYAMA ,  Satoshi UMEZAKI ,  Yusuke SHIRAISHI ,  Kazuhiro ONUMA ,  Masahiro KOJIMA ,  Hayato NISHIYAMA ,  Tomio KIMURA

IPC分类号： C07F7/10

CPC分类号： C07F7/10 ,  A61K31/695 ,  Y02P20/55

摘要： Provided is a compound represented by formula (I) or a pharmacologically acceptable salt thereof: wherein L1 is an optionally substituted C1-6 alkylene group or the like, L2 is a single bond or the like, L3 is a single bond or the like, R1, R2, and R3 are each independently an optionally substituted C1-4 alkyl group or the like, R4 is a hydrogen atom or the like, and R5 is a hydrogen atom or the like.